Lixelle Beta 2-Microglobulin Apheresis Column

Some patients with progressive kidney failure present a buildup of beta2-microglobulins in their blood which damages joints, tendons, bones and organs. Recently, the USFDA has approved an apheresis device called “the Lixelle Column” to remove the harmful proteins. Though it’s called an apheresis appliance, it seems more like a hematopietic stem cell isolator. Inside the column, porous cellulose beads bind the beta-2 microglobulins as blood flows through before going into a dialysis machine. MORE

Image Credit:   FDA.gov